RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jean-Paul Humbert Emilie Laboureyras Benoit Petit-Demoulière Isabelle Bertin Jean-Jacques Bourguignon Frédéric Bihel |
| Publication date | March 10, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |